The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: The Heart and Estrogen-Progestin Replacement Study (HERS)

Annals of Epidemiology

Volumn 16, Issue 2, 2006, Pages 138-145

  Simon, Joel A ^a,b,d   Lin, Feng ^b   Vittinghoff, Eric ^b   Bittner, Vera ^c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of Alabama at Birmingham   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiovascular Risk Factors; Estrogens; Hormones; Uric Acid

Indexed keywords

ESTROGEN; GESTAGEN; PLACEBO; URIC ACID;

ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HORMONAL THERAPY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; CREATININE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MEDROXYPROGESTERONE ACETATE; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRIGLYCERIDES; URIC ACID;

EID: 32044456257     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2005.04.003     Document Type: Article

References (58)

1. M.M. Gertler, S.M. Garn, and S.A. Levine Serum uric acid in relation to age and physique in health and in coronary heart disease Ann Intern Med 34 1951 1421 1431
2. P.M. Kohn, and G.B. Prozan Hyperuricemia: Relationship to hypercholesterolemia and acute myocardial infarction JAMA 170 1959 1909 1915
3. T.G. Benedek Correlations of serum uric acid and lipid concentrations in normal, gouty, and atherosclerotic men Ann Intern Med 66 1967 851 861
4. A. Kagan, T. Gordon, G.G. Rhoads, and J.C. Schiffman Some factors related to coronary heart disease incidence in Honolulu Japanese men: The Honolulu Heart Study Intl J Epidemiol 4 1975 271 279
5. M. Shoskes Systolic hypertension, hyperuricemia and hyperglycemia as risk factors in cardiovascular disease J Med Soc NY 73 1976 219 223
6. D. Jacobs Hyperuricemia as a risk factor in coronary heart disease Adv Exp Med Biol 76B 1979 231 237
7. V.W. Persky, A.R. Dyer, and E. Idris-Soven Uric acid: A risk factor for coronary heart disease? Circulation 59 1979 969 977
8. W.J. Fessel High uric acid as an indicator of cardiovascular disease. Independence of obesity Am J Med 68 1980 401 404
9. A. Reunanen, H. Takkunen, P. Knekt, and A. Aromaa Hyperuricemia as a risk factor for cardiovascular mortality Acta Medica Scand Suppl 668 1982 49 59
10. K. Yano, D.M. Reed, and D.L. McGee Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biological and lifestyle characteristics Am J Epidemiol 119 1984 653 666
11. F.N. Brand, D.L. McGee, W.B. Kannel, J. Stokes, and W.P. Castelli Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study Am J Epidemiol 121 1985 11 18
12. C. Bengtsson, L. Lapidus, C. Stendahl, and J. Waldenstrom Hyperuricemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothernburg, Sweden Acta Medica Scand 224 1988 549 555
13. W. Levine, A.R. Dyer, R.B. Shekelle, J.A. Schoenberger, and J. Stamler Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry J Clin Epidemiol 42 1989 257 267
14. W. Rathmann, H. Hauner, K. Dannehl, and F.A. Gries Association of elevated serum uric acid with coronary heart disease in diabetes mellitus Diabetes Metab 19 1993 159 166
15. A.R. Dyer, R. Stamler, J. Stamler, and D. Garside Serum uric acid and 18-year cardiovascular mortality in the Chicago Heart Association Detection Project in Industry A.M. Gotto C. Lenfant R. Paoletti M. Soma Multiple risk factors in cardiovascular disease 1995 Kluwer Academic Publishers Milan, Italy 365 372
16. D.S. Freedman, D.F. Williamson, E.W. Gunter, and T. Byers Relation of serum uric acid to mortality and ischemic heart disease: The NHANES I Epidemiologic Follow-up Study Am J Epidemiol 141 1995 637 644
17. J. Fang, and M.H. Alderman Serum uric acid and cardiovascular mortality: the NHANES I Epidemiologic Follow-up Study, 1971-1992 JAMA 283 2000 2404 2410
18. A.R. Myers, F.H. Epstein, H.J. Dodge, and W.M. Mikkelsen The relationship of serum uric acid to risk factors in coronary heart disease Am J Med 45 1968 520 528
19. C. Allard, and C. Goulet Serum uric acid: Not a discriminator of coronary heart disease in men and women Can Med Assoc 109 1973 986 988
20. R. Klein, B.E. Klein, J.C. Cornoni, J. Maready, J.C. Cassel, and H.A. Tyroler Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, GA Arch Intern Med 132 1973 401 410
21. The Coronary Drug Project Research Group Serum uric acid: its association with other risk factors and with mortality in coronary heart disease J Chronic Dis 29 1976 557 569
22. K. Yano, G. Rhoads, and A. Kagan Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii J Chronic Dis 30 1977 171 184
23. W.B. Kannel Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study Am Heart J 114 1987 413 419
24. J. Lee, D. Sparrow, P.S. Vokonas, L. Landsberg, and S.T. Weiss Uric acid and coronary heart disease risk: evidence for a role of uric acid in obesity-insulin resistance syndrome Am J Epidemiol 142 1995 288 294
25. C. Iribarren, A.R. Folsom, J.H. Eckfeldt, P.G. McGovern, and F.J. Nieto Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: The ARIC Study Ann Epidemiol 6 1996 331 440
26. S.G. Wannamethee, A.G. Shaper, and P.H. Whincup Serum urate and the risk of major coronary heart disease events Heart 78 1997 147 153
27. J.T. Moriarity, A.R. Folsom, C. Iribarren, F.J. Nieto, and W.D. Rosamond Serum uric acid and risk of coronary heart disease: Atherosclerosis Risk in Communities (ARIC) Study Ann Epidemiol 10 2000 136 143
28. B.F. Culleton, M.G. Larson, W.B. Kannel, and D. Levy Serum uric acid and risk for cardiovascular disease and death: The Framingham Study Ann Intern Med 131 1999 7 13
29. M. Kuzuya, F. Ando, A. Iguchi, and H. Shimokata Effect of aging on serum uric acid levels: longitudinal changes in a large Japanese population group J Gerontol A Biol Sci Med Sci. 57 2002 M660 M664
30. J. Tuomilehto, P. Zimmet, E. Wolf, R. Taylor, P. Ram, and H. King Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji Am J Epidemiol 127 1988 321 336
31. F.C. Facchini, Y.D. Chen, C.B. Hollenbeck, and G.M. Reaven Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentrations JAMA 266 1991 3008 3011
32. F. Jossa, E. Farinaro, S. Panico, V. Krogh, E. Celentano, and R. Galasso Serum uric acid and hypertension: the Olivetti Heart Study J Hum Hypertens 8 1994 677 681
33. E. Bonora, G. Targher, M.B. Zenere, F. Saggiani, V. Cacciatori, and F. Tosi Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution: The Verona Young Men Atherosclerosis Risk Factors Study Intl J Obes Relat Metab Disord 20 1996 975 980
34. I. Zavaroni, E. Bonora, M. Pagliara, E. Dall'Aglio, L. Luchetti, and G. Buonanno Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance N Engl J Med 320 1989 702 706
35. C. Russo, O. Olivieri, D. Girelli, P. Guarini, and R. Corrocher Relationships between serum uric acid and lipids in healthy subjects Prev Med 25 1996 611 616
36. F.H. Messerli, E.D. Frohlich, G.R. Dreslinski, D.H. Suarez, and G.G. Aristimuno Serum uric acid in essential hypertension: An indicator of renal vascular involvement Ann Intern Med 93 1980 817 821
37. E.D. Frohlich Uric acid: A risk factor for coronary heart disease JAMA 270 1993 378 379
38. A. Nichols, M.L. Snaith, and J.T. Scott Effect of oestrogen therapy on plasma and urinary levels of uric acid BMJ 1973 1973 449 451
39. H. Sumino, S. Ichikawa, T. Kanda, T. Nakamura, and T. Sakamaki Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricemia Lancet 354 1999 650
40. S. Hulley, D. Grady, T. Bush, C. Furberg, D. Herrington, and B. Riggs Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women JAMA 280 1998 605 613
41. D. Grady, W. Applegate, T. Bush, C. Furberg, B. Riggs, and S.B. Hulley Heart and Estrogen/progestin Replacement Study (HERS): Design, methods, and baseline characteristics Controlled Clin Trials 19 1998 314 335
42. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem. 18 1972 499 502
43. N.B. Tietze Fundamentals of Clinical Chemistry 1987 WB Saunders Co. Philadelphia
44. Expert Panel on the Detection, Evaluation, and treatment of high blood cholesterol in adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on the detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
45. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
46. SAS. 2001. Statistical analysis system. Version 8.02. SAS Institute, Cary, NC.
47. F.M. Anton, J. Garcia Puig, T. Ramos, P. Gonzalez, and J. Ordas Sex differences in uric acid metabolism in adults: Evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate Metabol 35 1986 343 348
48. J.F. Mustard, E.A. Murphy, and M.A. Ogryzlo Blood coagulation and platelet economy in subjects with primary gout Can Med Assoc J 89 1963 1207 1211
49. H. Newland Hyperuricemia in coronary, cerebral, and peripheral arterial disease: an explanation Med Hypotheses 1 1975 152 155
50. J.V. Selby, G.D. Friedman, and C.P. Quesenberry Jr. Precursors of essential hypertension Am J Epidemiol 131 1990 1017 1027
51. R.J. Johnson, D.-H. Kang, D. Feig, S. Kivlighn, J. Kanellis, and S. Watanabe Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertens 41 2003 1183 1190
52. G.N. Rao, M.A. Corson, and B.C. Berk Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression J Biol Chem 266 1991 8604 8608
53. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction: The Anturane Reinfarction Study N Engl J Med 298 1978 289 295
54. The Anturane Trial Research Group Sulfinpyrazone in the prevention of sudden death after myocardial infarction N Engl J Med 302 1980 250 256
55. Sulphinpyrazone in post-myocardial infarction Report from the Anturan Reinfarction Italian Study Lancet 1 1982 237 242
56. R. Temple, and G.W. Pledger The FDA's critique of the Anturane Reinfarction Trial N Engl J Med 303 1980 1488 1492
57. The Anturane Reinfarction Trial: Reevaluation of outcome N Engl J Med 306 1982 1005 1008
58. J.A. Cairns, M. Gent, J. Singer, K.J. Finnie, G.M. Froggatt, and D.A. Holder Aspirin, sulfinpyrazone, or both in unstable angina: Results of a Canadian multicenter trial N Engl J Med 313 1985 1369 1375